Second Autologous Hematopoietic Stem Cell Transplant as Salvage Therapy for Relapsed Multiple Myeloma: A Global Treatment Option for Eligible Patients

被引:4
|
作者
Gonsalves, Wilson I. [1 ]
Kansagra, Ankit [2 ]
机构
[1] Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
[2] UT Southwestern, Dept Med, Hematol, Dallas, TX USA
关键词
D O I
10.1159/000486272
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:45 / 46
页数:2
相关论文
共 50 条
  • [41] AUTOLOGOUS STEM CELL TRANSPLANT WITH NON CRYOPRESERVED HEMATOPOIETIC STEM CELL IN ALGERIAN PATIENTS WITH MULTIPLE MYELOMA
    Bekadja, A.
    Talhi, S.
    Amani, K.
    Brahimi, M.
    Osmani, S.
    Yafour, N.
    Krim, A.
    Bouhass, R.
    HAEMATOLOGICA, 2016, 101 : 629 - 629
  • [42] Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
    Marek Hus
    Norbert Grzasko
    Marta Szostek
    Andrzej Pluta
    Grzegorz Helbig
    Dariusz Woszczyk
    Maria Adamczyk-Cioch
    Dariusz Jawniak
    Wojciech Legiec
    Marta Morawska
    Justyna Kozinska
    Piotr Waciński
    Anna Dmoszynska
    Annals of Hematology, 2011, 90 : 1161 - 1166
  • [43] Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
    Hus, Marek
    Grzasko, Norbert
    Szostek, Marta
    Pluta, Andrzej
    Helbig, Grzegorz
    Woszczyk, Dariusz
    Adamczyk-Cioch, Maria
    Jawniak, Dariusz
    Legiec, Wojciech
    Morawska, Marta
    Kozinska, Justyna
    Wacinski, Piotr
    Dmoszynska, Anna
    ANNALS OF HEMATOLOGY, 2011, 90 (10) : 1161 - 1166
  • [44] Second Autologous Stem Cell Transplant as Salvage in Multiple Myeloma - The Oregon Health and Science University Experience
    Galligan, Derek
    Williamson, Staci
    Myers, Jessie
    Silbermann, Rebecca
    Medvedova, Eva
    Nagle, Sarah
    Schachter, Levanto
    Chen, Andy
    Scott, Emma
    Maziarz, Richard
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (02): : 105 - 112
  • [45] The efficacy of Salvage Autologous Stem Cell Transplant for Patients With Multiple Myeloma Who Received Maintenance Therapy Post an Initial Transplant
    King, Justin
    Fiala, Mark
    Kohnen, Daniel
    Stockerl-Goldstein, Keith
    Wildes, Tanya
    Vij, Ravi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E70 - E71
  • [46] Stem cell transplant: an effective salvage therapy for multiple myeloma
    Gertz, Morie A.
    LEUKEMIA & LYMPHOMA, 2011, 52 (08) : 1413 - 1414
  • [47] Influence of Malnutrition on the Outcomes of Autologous Hematopoietic Stem Cell Transplant in Multiple Myeloma Patients
    Deenadayalan, Vaishali
    Nagadia, Urja
    Litvin, Rafaella
    Obeidat, Khaldun
    Rifkin, Shelby D.
    Zia, Maryam
    BLOOD, 2022, 140 : 11139 - 11139
  • [48] The Efficacy of Salvage Autologous Stem Cell Transplant for Patients with Multiple Myeloma Who Received Maintenance Therapy Following Initial Transplant
    King, Justin A.
    Fiala, Mark A.
    Kohnen, Daniel R.
    Wildes, Tanya M.
    Stockerl-Goldstein, Keith
    Vij, Ravi
    BLOOD, 2016, 128 (22)
  • [49] Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?
    Moreau, Philippe
    Rajkumar, S. Vincent
    LEUKEMIA RESEARCH, 2012, 36 (06) : 677 - 681
  • [50] Salvage Allogeneic Hematopoietic Cell Transplantation for Relapsed or Progressive Multiple Myeloma After Autologous Hematopoietic Cell Transplantation
    Schneidawind, Dominik
    Oehrlein, Katharina
    Weisel, Katja C.
    Faul, Christoph
    Kanz, Lothar
    Bethge, Wolfgang A.
    BLOOD, 2012, 120 (21)